Skip to main content

Integrative Treatments for Masked Anxiety and PTSD in Highly Sensitive Patients

  • Chapter
  • First Online:
Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders

Abstract

Although anxiety is not always the most obvious symptom in complex cases, it must be recognized and addressed. The following four cases represent unrecognized atypical presentations of anxiety disorders and posttraumatic stress disorder (PTSD) in patients who did not respond well to conventional psychotropic medications. In these cases, affective, cognitive, and behavioral symptoms significantly improved with integrative treatments combining medicinal herbs, nootropics, other complementary approaches, and in some cases prescription psychotropic medications. When stress-related physical symptoms, such as dystonias, become the focus of treatment, the anxiety underlying the physical condition may escape notice. Patients who do not respond well to conventional medications or who have drug sensitivities are often mislabeled as “treatment-resistant.” The urgent need for behavioral control of patients with developmental disorders, learning disabilities, and communication impairments often leads to the overuse of sedating major tranquilizers that miss the real target symptoms and exacerbate underlying cognitive and coordination dysfunctions. The treatment of anxiety, depression, and mild cognitive impairment in elderly patients with mild herbal formulas can significantly improve quality of life. Patients who do not respond adequately to prescription psychotropics and those who are sensitive to medication side effects are a large subgroup of people who benefit most from integrative and complementary approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jellin PG, Gregory PJ. Pharmacist’s letter/prescriber’s letter natural medicines comprehensive database. 12th ed. Therapeutic Research: Stockton; 2009.

    Google Scholar 

  2. White DJ et al. Anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: a randomised, double-blind, placebo-controlled, crossover trial. Nutrients. 2016;8(1):53–72.

    Google Scholar 

  3. Lardner AL. Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders. Nutr Neurosci. 2014;17(4):145–55.

    Article  CAS  PubMed  Google Scholar 

  4. Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. In: Muskin PR, Gerbarg PL,Brown RP editors. Complementary and Integrative Therapies for Psychiatric Disorders. Psych Clin NA. 2013;36(1):169–176.

    Google Scholar 

  5. Sageman S, Brown RP. 3-Acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports [2]. J Clin Psychiatry. 2006;67(3):493–6.

    Article  PubMed  Google Scholar 

  6. Rasmusson AM et al. An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacol. 2004;29(8):1546–57.

    Article  CAS  Google Scholar 

  7. Mohamadpour AH et al. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci. 2013;16(1):39–46.

    PubMed  PubMed Central  Google Scholar 

  8. Shahmansouri N et al. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord. 2014;155(1):216–22.

    Article  CAS  PubMed  Google Scholar 

  9. Modabbernia A, Akhondzadeh S. Saffron, passionflower, valerian and sage for mental health. Psychiatr Clin N Am. 2013;36(1):85–91.

    Article  Google Scholar 

  10. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment foranxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complementary Med. 2014;20(12):901–8. doi: 10.1089/acm.2014.0177.

  11. Delalleau B et al. Analysis of the side effects of tianeptine. Clin Neuropharmacol. 1988;11(Suppl 2):S83–9.

    PubMed  Google Scholar 

  12. Atmaca M et al. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum Psychopharmacol. 2003;18(4):277–80.

    Article  PubMed  Google Scholar 

  13. JA C e S. From restoration of neuroplasticity to the treatment of depression: clinical experience. Eur Neuropsychopharmacol. 2004;14(Suppl 5):S511–21.

    Google Scholar 

  14. Zoladz PR, Fleshner M, Diamond DM. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD. ProgNeuro-Psychopharmacol Biol Psychiatry. 2013;44:1–16.

    Article  CAS  Google Scholar 

  15. Streeter CC et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78(5):571–9.

    Article  CAS  PubMed  Google Scholar 

  16. Abdou AM et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid(GABA) administration in humans. Biofactors. 2006;26(3):201–8.

    Article  CAS  PubMed  Google Scholar 

  17. Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 2005;11(2):169–82.

    Article  CAS  PubMed  Google Scholar 

  18. Winnicka K, Tomasiak M, Bielawska A. Piracetaman old drug with novel properties? Acta Pol PharmDrug Res. 2005;62(5):405–9.

    CAS  Google Scholar 

  19. He Z et al. Piracetam ameliorated oxygen and glucose deprivation-induced injury in rat cortical neurons via inhibition of oxidative stress, excitatory amino acids release and P53/Bax. Cell Mol Neurobiol. 2014;34(4):539–47.

    Article  CAS  PubMed  Google Scholar 

  20. Graham KA et al. Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. Am J Psychiatry. 2005;162(9):1744–6.

    Article  PubMed  Google Scholar 

  21. Brown RP, Gerbarg PL. Complementary and integrative treatments in brain injury. In: Silver JM, McAllister TW, Yudofsky SC, editors. Textbook of traumatic brain injury. 2 ed. Washington, DC: American Psychiatric Press, Inc.; 2011. p. 599–622.

    Google Scholar 

  22. Gerbarg PL, Brown RP. Phytomedicines for prevention and treatment of mental health disorders. Psychiatric Clin N Am. 2013;36(1):37–47.

    Article  Google Scholar 

  23. Van Strien AM et al. Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas. 2013;74(4):357–62.

    Article  CAS  PubMed  Google Scholar 

  24. Gustafsson M et al. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings. Int Psychogeriatrics. 2013;25(9):1415–23.

    Article  Google Scholar 

  25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5. ed. Arlington: American Psychiatric Association; 2013.

    Google Scholar 

  26. Li LT et al. The beneficial effects of the herbal medicine free and easy wanderer plus (FEWP) and fluoxetine on post-stroke depression. J Altern Complement Med. 2008;14(7):841–6.

    Article  PubMed  Google Scholar 

  27. Qin F et al. Meta-analysis of randomized controlled trials to assess the effectiveness and safety of free and easy wanderer plus, a polyherbal preparation for depressive disorders. JPsychiatr Res. 2011;45(11):1518–24.

    Article  Google Scholar 

  28. Wang HN et al. Free and Easy Wanderer Plus (FEWP), a polyherbal preparation, ameliorates PTSD-like behavior and cognitive impairments in stressed rats. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(8):1458–63.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia L. Gerbarg MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gerbarg, P.L., Brown, R.P. (2017). Integrative Treatments for Masked Anxiety and PTSD in Highly Sensitive Patients. In: Camfield, D., McIntyre, E., Sarris, J. (eds) Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-42307-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42307-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42305-0

  • Online ISBN: 978-3-319-42307-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics